Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complement metabolism in the seronegative arthritides.

× No keyword cloud information.

34 in total

1. A simple method for producing antibody specific to a single selected diffusible antigen.

Authors: R B Goudie; C H Horne; P C Wilkinson
Journal: Lancet Date: 1966-12-03 Impact factor: 79.321

2. Reactions in agarose gel between C1q and aggregated gamma globulin.

Authors: S Thunold; C J Abeyounis; F Milgrom
Journal: J Immunol Date: 1970-03 Impact factor: 5.422

3. Reactive haemolysis--a distinctive form of red cell lysis.

Authors: R A Thompson; D S Rowe
Journal: Immunology Date: 1968-05 Impact factor: 7.397

4. Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases.

Authors: J H Vaughan; E V Barrnett; M V Sobel; R F Jacox
Journal: Arthritis Rheum Date: 1968-04

5. Raised IgG antiglobulin factors in Still's disease.

Authors: G Torrigiani; B M Ansell; E E Chown; I M Roitt
Journal: Ann Rheum Dis Date: 1969-07 Impact factor: 19.103

6. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.

Authors: H Hedberg; B Lundh; A B Laurell
Journal: Clin Exp Immunol Date: 1970-05 Impact factor: 4.330

7. [Studies on hemolytic complement in certain osteoarticular diseases. Over-all results].

Authors: A Peltier; F Coste; F Delbarre
Journal: Presse Med Date: 1966-06-11 Impact factor: 1.228

8. Breakdown products of C 3 in human synovial fluids.

Authors: N J Zvaifler
Journal: J Clin Invest Date: 1969-08 Impact factor: 14.808

9. Serum complement, rheumatoid factor, and other serum proteins in rheumatoid disease and systemic lupus erythematosus.

Authors: H A ELLIS; D FELIX-DAVIES
Journal: Ann Rheum Dis Date: 1959-09 Impact factor: 19.103

10. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors: R A Thompson; P J Lachmann
Journal: J Exp Med Date: 1970-04-01 Impact factor: 14.307

8 in total

1. Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis.

Authors: B Duquesnoy; F Santoro; P Wattre; B Delcambre
Journal: Ann Rheum Dis Date: 1980-10 Impact factor: 19.103

2. The in-vivo metabolism of C3 in ankylosing spondylitis.

Authors: L Brinch; O Vinje; P Teisberg; O J Mellbye; I Aakesson
Journal: Ann Rheum Dis Date: 1982-02 Impact factor: 19.103

3. The absence of circulating immune complexes in patients with ankylosing spondylitis.

Authors: W Maksymowych; M K Dasgupta; R S Rothwell; J B Dossetor; A S Russell
Journal: Rheumatol Int Date: 1981 Impact factor: 2.631

4. Circulating immune complexes in patients with ankylosing spondylitis.

Authors: G S Panayi; J Slaney; B D Williams
Journal: Ann Rheum Dis Date: 1980-10 Impact factor: 19.103

5. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.

Authors: C Bruneau; H Bonin
Journal: Clin Exp Immunol Date: 1983-09 Impact factor: 4.330

6. Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew's syndrome) and their relatives.

Authors: O Vinje; P Møller; J Mellbye
Journal: Clin Rheumatol Date: 1984-12 Impact factor: 2.980

7. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.

Authors: U E Nydegger; R H Zubler; R Gabay; G Joliat; C H Karagevrekis; P H Lambert; P A Miescher
Journal: J Clin Invest Date: 1977-05 Impact factor: 14.808

8. Modulation of the alternative complement pathways by beta 1 H globulin.

Authors: K Whaley; S Ruddy
Journal: J Exp Med Date: 1976-11-02 Impact factor: 14.307

8 in total